Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Katzenschlager R, Hirschl M, Minar E, Ugurluoglu A
Liposomal Heparin-Spraygel in Comparison with Subcutaneous Low Molecular Weight Heparin in Patients with Superficial Venous Thrombosis. A Randomized, Controlled, Open Multicentre Study
Journal für Kardiologie - Austrian Journal of Cardiology 2003; 10 (9): 375-378

Volltext (PDF)    Summary    Übersicht   

Aktuelles Bild - Abb. 1: Thrombus - Schmerz - Heparin Abb. 2: Thrombus - Heparin - Erythem
Abbildung 1: Thrombus - Schmerz - Heparin
The mean differences of pain scores. In both groups, pain reduction between the baseline and day 7 were statistically significant (p<0.01). On day 14 in both groups the median pain VAS scores were 0 in both groups of patients. The intergroup differences were negligliable at any point. The pain assessed by VRS paralleled the values of pain reduction obtained by VAS. There were no differences between the groups concerning the pain rescue medication consumption.
 
Thrombus - Schmerz - Heparin
Vorheriges BildNächstes Bild   


Abbildung 1: Thrombus - Schmerz - Heparin
The mean differences of pain scores. In both groups, pain reduction between the baseline and day 7 were statistically significant (p<0.01). On day 14 in both groups the median pain VAS scores were 0 in both groups of patients. The intergroup differences were negligliable at any point. The pain assessed by VRS paralleled the values of pain reduction obtained by VAS. There were no differences between the groups concerning the pain rescue medication consumption.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung